Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03055767 · ClinicalTrials.gov registry record · Phase 2
Effectiveness of Onabotulinumtoxin A (Botox) in Pediatric Patients Experiencing Migraines: A Study in the Pediatric Pain Population
A Phase 2 study, sponsored by University of California, Irvine.
- Completed
- Registry status
- Phase 2
- Development phase
- 17
- Enrollment target
NCT03055767 is a Phase 2 study that has completed, run by University of California, Irvine. The registered enrollment target is 17 participants.
The verdict
NCT03055767, a Phase 2 study, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 17 participants
- Enrollment target
Study Summary
The purpose of the research is to examine the outcomes of pediatric patients receiving Botulinum toxin type A (Botox ®) for the treatment of migraine. There is limited literature on the effectiveness of Botox ® in the treatment of chronic neurological pain in pediatric patients, specifically in the treatment of migraines.
Interventions
- DRUG OnabotulinumtoxinA
- OTHER Placebo (Saline)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2017-03-01 |
| Est. Completion | 2020-04-20 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03055767
The ClinicalTrials.gov registry entry for NCT03055767 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which OnabotulinumtoxinA is the first listed.
NCT03055767 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03055767 about?
NCT03055767 is a clinical study titled "Effectiveness of Onabotulinumtoxin A (Botox) in Pediatric Patients Experiencing Migraines: A Study in the Pediatric Pain Population". The purpose of the research is to examine the outcomes of pediatric patients receiving Botulinum toxin type A (Botox ®) for the treatment of migraine. There is limited literature on the effectiveness of Botox ® in the treatment of chronic neurological pain in pediatric patients, specifically in the ...
What is the current status of trial NCT03055767?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 17 participants. The study started on 2017-03-01. Estimated completion is 2020-04-20.
What interventions are being tested in trial NCT03055767?
The interventions under investigation include: OnabotulinumtoxinA (DRUG), Placebo (Saline) (OTHER).
Who is sponsoring clinical trial NCT03055767?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.